# Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy.

> **NCT00878826** · PHASE2,PHASE3 · COMPLETED · sponsor: **Stanford University** · enrollment: 11 (actual)

## Conditions studied

- Venous Thrombosis

## Interventions

- **DRUG:** Enoxaparin

## Key facts

- **NCT ID:** NCT00878826
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2011-08
- **Final completion:** 2014-10
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2016-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00878826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00878826, "Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy.". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT00878826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*